Latest tuberculosis Stories
NEW YORK, May 21, 2013 /PRNewswire-USNewswire/ -- In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications. (Logo:...
A new 5-year guarantee through Pledge Guarantee for Health (PGH) has the potential to unlock immense private sector financing, accelerating efforts to achieve MDGs. New York, NY (PRWEB) May 17, 2013 Today, leading global health and development experts from the public and private sectors are joining forces at the 2013 GBCHealth Conference to announce a new partnership that will leverage private sector funding to speed up delivery and access to life-saving health supplies such as...
A handheld diagnostic device that Massachusetts General Hospital (MGH) investigators first developed to diagnose cancer has been adapted to rapidly diagnose tuberculosis (TB) and other important infectious bacteria. Two papers appearing in the journals Nature Communications and Nature Nanotechnology describe portable devices that combine microfluidic technology with nuclear magnetic resonance (NMR) to not only diagnose these important infections but also determine the presence of...
Awards Recognize Businesses for Ground-Breaking Work in Addressing Global Health Threats New York, NY (PRWEB) May 03, 2013 GBCHealth announced today the winners of the Business Action on Health Awards. The awards recognize the world’s best corporate-supported programs that address global health needs. Awards will be presented to winning companies at the GBCHealth annual conference on May 15-17 in New York City. It is the only event focused exclusively on the role of business in...
LUND, Sweden, April 30, 2013 /PRNewswire/ -- On April 26(th), 2013, TFS International (TFS) has completed the acquisition of the New Jersey based Oncology and Vaccine specialist Contract Research Organization (CRO), Beardsworth Consulting Group, Inc. (BCG). In a move to expand its oncology and vaccine research services, TFS has announced the completion of acquiring BCG, an independent clinical CRO with headquarters in Flemington, New Jersey, and with clinical research...
Researchers are 1 step closer to understanding why antibiotics are ineffective against certain types of bacteria Antibiotic resistance is a global problem. The World Health Organisation (WHO) estimates that for tuberculosis alone multi-drug resistance accounts for more than 150,000 deaths each year. WHO warns of "a doomsday scenario of a world without antibiotics," in which antibiotic resistance will turn common infections into incurable killers and make routine surgeries a high-risk...
BETHESDA, Md., April 22, 2013 /PRNewswire-USNewswire/ -- The National Foundation for Infectious Diseases will host the 16(th )Annual Conference on Vaccine Research, April 22-24, 2013, at the Hyatt Regency Inner Harbor in Baltimore, MD. This three-day conference presents high-quality, current reports of scientific progress and best practices in both invited presentations and submitted oral abstracts and posters. The conference brings together the diverse disciplines involved in the...
Congress Passes Bill Maintaining Full Support for Global Fund WASHINGTON, March 21, 2013 /PRNewswire-USNewswire/ --Today Congress reinforced the United States' commitment to global health, passing a continuing resolution (CR) that secures robust funding for the Global Fund to Fight AIDS, Tuberculosis and Malaria. Despite a constrained budget environment, the bill recognizes the critical needs met by the Global Fund and its partners, providing $1.65 billion for the fight against these...
24 March World Tuberculosis Day WASHINGTON, March 21, 2013 /PRNewswire/ -- Today, on its 110th anniversary, KNCV Tuberculosis Foundation has honored the U.S. Agency for International Development (USAID) for its exceptional dedication and wise leadership in the worldwide fight against tuberculosis (TB). Gerdy Schippers, Director of KNCV Tuberculosis Foundation: "On this occasion we proudly recognize the USA's tremendous contribution towards winning the battle...
Replikins Synthetic Vaccines Against Antibiotic-Resistant Gonococcus, Tuberculosis, Staphylococcus, Streptococcus, Klebsiella KPC, and Cl. Difficile OTTAWA, Ontario, March 14, 2013 /PRNewswire/ -- A group of lethal bacteria are of increasing concern worldwide because they are becoming resistant to many or all of the antibiotics previously effective against them (1). Bioradar UK Ltd. announced today in Ottawa, Canada that it has discovered that the concentration of genomic Replikins...
Latest tuberculosis Reference Libraries
Mycobacterium tuberculosis (MTB) is a pathogenic bacterial species in the genus Mycobacterium and the causative agent of most cases of tuberculosis. Robert Koch first discovered it in 1882 and that it had an unusual, waxy coating on the cell surface which makes them impossible to Gram stain. M. tuberculosis is highly aerobic and requires high levels of oxygen. It generally infects the respiratory system of mammals. Tuberculin skin test, acid-fast stain, and chest radiographs are the most...
Mycobacterium bovis is a slow-growing, aerobic bacterium and the causative agent of tuberculosis in cattle. Similar to M. tuberculosis, M. bovis can jump the species barrier and cause tuberculosis in humans. It is estimated that M. bovis was responsible for more losses among farm animals than all other diseases combined in the first half of the 20th century. Infection happens after bacterium is ingested. It is generally transmitted to humans via infected milk. Actual human infections are...
